These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 8322779)

  • 1. Verapamil prevents chronic renal failure-induced abnormalities in lipid metabolism.
    Akmal M; Perkins S; Kasim SE; Oh HY; Smogorzewski M; Massry SG
    Am J Kidney Dis; 1993 Jul; 22(1):158-63. PubMed ID: 8322779
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Abnormalities in hepatic lipase in chronic renal failure: role of excess parathyroid hormone.
    Klin M; Smogorzewski M; Ni Z; Zhang G; Massry SG
    J Clin Invest; 1996 May; 97(10):2167-73. PubMed ID: 8636395
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of secondary hyperparathyroidism in the genesis of hypertriglyceridemia and VLDL receptor deficiency in chronic renal failure.
    Liang K; Oveisi F; Vaziri ND
    Kidney Int; 1998 Mar; 53(3):626-30. PubMed ID: 9507207
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Derangements in acetylcholine metabolism in brain synaptosomes in chronic renal failure.
    Ni Z; Smogorzewski M; Massry SG
    Kidney Int; 1993 Sep; 44(3):630-7. PubMed ID: 8231038
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correction of glucose intolerance and the impaired insulin release of chronic renal failure by verapamil.
    Fadda GZ; Akmal M; Soliman AR; Lipson LG; Massry SG
    Kidney Int; 1989 Nov; 36(5):773-9. PubMed ID: 2559234
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Secondary hyperparathyroidism downregulates lipoprotein lipase expression in chronic renal failure.
    Vaziri ND; Wang XQ; Liang K
    Am J Physiol; 1997 Dec; 273(6):F925-30. PubMed ID: 9435681
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Parathyroid hormone interferes with extrarenal disposition of potassium in chronic renal failure.
    Soliman AR; Akmal M; Massry SG
    Nephron; 1989; 52(3):262-7. PubMed ID: 2739866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreased O2 consumption by PMNL from humans and rats with CRF: role of secondary hyperparathyroidism.
    Kiersztejn M; Smogorzewski M; Thanakitcharu P; Fadda GZ; Massry SG
    Kidney Int; 1992 Sep; 42(3):602-9. PubMed ID: 1405338
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PTH-PTHrP receptor mRNA is downregulated in chronic renal failure.
    Tian J; Smogorzewski M; Kedes L; Massry SG
    Am J Nephrol; 1994; 14(1):41-6. PubMed ID: 8017480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Down-regulation of tissue lipoprotein lipase expression in experimental chronic renal failure.
    Vaziri ND; Liang K
    Kidney Int; 1996 Dec; 50(6):1928-35. PubMed ID: 8943476
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Abnormal leucine-induced insulin secretion in chronic renal failure.
    Oh HY; Fadda GZ; Smogorzewski M; Liou HH; Massry SG
    Am J Physiol; 1994 Nov; 267(5 Pt 2):F853-60. PubMed ID: 7977790
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pathomechanism of hyperlipoproteinemia in chronic renal failure].
    Rutkowski B; Łososowska R; Król E; Kisielnicka E; Zdrojewski Z; Szołkiewicz M; Niewegłowski T; Chmielewski M; Sucajtys E; Swierczyński J; Korczyńska J; Stelmańska E; Goyke E; Bogusławski W
    Pol Merkur Lekarski; 2003 Oct; 15(88):322-3; discussion 323-5. PubMed ID: 14974358
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impaired Na(+)-H+ exchanger activity of hepatocytes in chronic renal failure.
    Michnowska M; Smogorzewski M; Massry SG
    J Am Soc Nephrol; 1997 Jun; 8(6):929-34. PubMed ID: 9189860
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Excess parathyroid hormone adversely affects lipid metabolism in chronic renal failure.
    Akmal M; Kasim SE; Soliman AR; Massry SG
    Kidney Int; 1990 Mar; 37(3):854-8. PubMed ID: 2313975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of verapamil on CRF-induced abnormalities in phospholipid contents of brain synaptosomes.
    Islam A; Smogorzewski M; Massry SG
    Proc Soc Exp Biol Med; 1990 May; 194(1):16-20. PubMed ID: 2158110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Verapamil reverses PTH- or CRF-induced abnormal fatty acid oxidation in muscle.
    Perna AF; Smogorzewski M; Massry SG
    Kidney Int; 1988 Dec; 34(6):774-8. PubMed ID: 3210537
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Verapamil prevents the metabolic and functional derangements in pancreatic islets of chronic renal failure rats.
    Thanakitcharu P; Fadda GZ; Hajjar SM; Massry SG
    Endocrinology; 1991 Oct; 129(4):1749-54. PubMed ID: 1833176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Altered cytosolic calcium homeostasis in rat cardiac myocytes in CRF.
    Zhang YB; Smogorzewski M; Ni Z; Massry SG
    Kidney Int; 1994 Apr; 45(4):1113-9. PubMed ID: 8007581
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic parathyroid hormone excess in vivo increases resting levels of cytosolic calcium in brain synaptosomes: studies in the presence and absence of chronic renal failure.
    Smogorzewski M; Koureta P; Fadda GZ; Perna AF; Massry SG
    J Am Soc Nephrol; 1991 Apr; 1(10):1162-8. PubMed ID: 1768811
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Verapamil reverses glucose intolerance in preexisting chronic renal failure: studies on mechanisms.
    Thanakitcharu P; Fadda GZ; Hajjar SM; Levi E; Stojceva-Taneva O; Massry SG
    Am J Nephrol; 1992; 12(3):179-87. PubMed ID: 1329512
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.